GlassScriptPhysician profile
Christopher J Busken
NPI 1548313455
$45,578.96
in general payments reported to CMS, 2019-2025
34 companies · $33K in 2025
The $33K reported for 2025 was more than what 96% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,613 · 2020: $2,350 · 2021: $2,182 · 2022: $1,492 · 2023: $1,980 · 2024: $2,457 · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Food and Beverage: $8,061 · Travel and Lodging: $4,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,600.00 |
| Food and Beverage | $8,060.85 |
| Travel and Lodging | $4,279.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $32,394.95 | 2022-2025 | Torus Stent Graft System, Endocross Device |
| Angiodynamics, INC. | $1,582.13 | 2020-2025 | Auryon Laser System 100-120 Vac |
| Inari Medical, INC. | $1,505.89 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiovascular Systems INC. | $1,266.08 | 2019-2023 | Diamondback Peripheral |
| W. L. Gore & Associates, INC. | $1,139.65 | 2022-2024 | Gore Tag Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Medtronic, INC. | $744.80 | 2021-2022 | |
| Cvrx, INC. | $734.61 | 2019-2022 | |
| Boston Scientific Corporation | $725.30 | 2019-2024 | Jetstream Sc, Wolverine Coronary Cutting Balloon, Eluvia |
| Getinge USA Sales, LLC | $721.65 | 2019-2022 | |
| Celonova Biosciences, INC. | $596.62 | 2020-2021 | |
| Medtronic Vascular, INC. | $573.57 | 2019-2020 | |
| Silk Road Medical, INC. | $501.22 | 2019-2021 | |
| Veryan Medical Incorporated | $462.16 | 2021-2024 | Biomimics 3d Vascular Stent System |
| Cook Medical LLC | $425.75 | 2019-2024 | Zilver Ptx, Zilver Vena |
| Philips North America LLC | $391.65 | 2019-2024 | (Az7) Lasers |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $314.82 | 2023-2025 | Indigo System, Ruby Coil |
| Organogenesis INC. | $212.85 | 2021-2023 | Puraply |
| Stryker Corporation | $209.16 | 2021-2025 | Clottriever Bold Catheter, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $200.02 | 2019-2023 | Xarelto |
| Bard Peripheral Vascular, INC. | $164.40 | 2019 | |
| Shockwave Medical, INC | $153.82 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Smith+Nephew, INC. | $100.32 | 2020-2022 | |
| Tactile Systems Technology INC | $93.33 | 2019-2021 | |
| Acist Medical Systems, INC. | $67.00 | 2021 | |
| Kerecis Limited | $62.78 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Bolton Medical INC | $53.32 | 2021-2023 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Integra Lifesciences Corporation | $35.90 | 2020-2022 | |
| Kci USA, INC. | $34.60 | 2021 | |
| Impulse Dynamics (USA) INC. | $28.31 | 2021 | |
| Elutia, INC. | $21.14 | 2019 | |
| Davol INC. | $19.82 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.59 | 2019 | |
| Polynovo North America LLC | $12.43 | 2021 | |
| Abbott Laboratories | $12.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Busken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.